Sputnik Light vs Sputnik V – Know the difference

All about Russia’s Sputnik vaccine

Sputnik Light, the single-dose version of Russia's Sputnik V vaccine has got the Drug Controller General of India (DCGI) approval for Phase III clinical trials in India. 

Sputnik V (Gam-Covid-Vac) is the world's first vaccine against coronavirus, registered in August 2020. Sputnik Light is its new first component based on human adenovirus serotype 26.

Sputnik V is a two-dose vaccine that targets the immune cells for quick antibody production. Sputnik Light is a single-dose vaccine that uses recombinant human adenovirus number 26 to transport requisite information into the system.

Sputnik Light is reportedly less effective against the Beta variant or coronavirus but offers good odds of protection against others, including the deadly Delta variant. It's said to be ideal for areas with acute outbreaks. This will also help in vaccinating more people as early as possible.

Sputnik Light shows 79.4 % efficacy as per the data from Russia’s mass vaccination programs while Sputnik V is 91.6% efficient against COVID-19 as per the reports published in The Lancet. 

Sputnik V Vaccine is developed by Russia’s Gamaleya Research Institute of Epidemiology and Microbiology. The central government has fixed Rs. 1145 as the maximum price of Sputnik V vaccine in private hospitals. Sputnik Light single-dose vaccine can come in October for consumers. Russian Direct Investment Fund (RDIF) has tied up with six Indian drug makers to manufacture Sputnik V. Dr. Reddy’s is in a pact with the Russian Direct Investment Fund to sell the first 125 million people doses (250 million vials) of COVID-19 vaccine Sputnik V in India.

Tags : #Spotlight #SputnikV #SputnikLight #COVIDVaccine #RussiasSputnik #COVID19 #RDIF #Medicircle #SmitaKumar

Related Stories

Loading Please wait...


Trending Now

Worldwide EndoMarch, Endo Run to raise mass awareness on Endometriosis!February 21, 2024
Uptick In Respiratory, and Cardiac Problems Due To Poor Air Quality In DelhiFebruary 21, 2024
Evidence shows risks associated with energy drinks in childrenFebruary 21, 2024
iHub-Data at IT-Hyderabad announces collaborative initiative with technical institutions for AI/ML training programsFebruary 20, 2024
Viatris Receives Global Minimized Risk of Antimicrobial Resistance Certification, Advancing its Commitment to Responsible Antibiotic ProductionFebruary 20, 2024
“Kusum Ka Biyaah” Indian Hindi film based on a true story releasing on 1st March 2024February 19, 2024
Introducing Moscow's Pioneering Initiative: An Open Dataset for AI-driven Brain Disease Detection"February 19, 2024
ICPA Health Products Introduces Coolora Spray - A Rapid Relief Solution For Oral & Throat DiscomfortFebruary 19, 2024
Section 43B of the Income Tax demystifiedFebruary 16, 2024
Nutricircle Introduces Health Supplements My45NutrientsTM to Enhance Overall Well-beingFebruary 16, 2024
YFLO organised a session “Design Your Story” to inspire young FICCI Ladies to design their own compelling storiesFebruary 15, 2024
149 experts call to find all TB to stop TBFebruary 15, 2024
ICPA Welcomes Global Leader In Periodontal Aesthetics - Prof Giovanni Zucchelli On His Inaugural Visit To IndiaFebruary 14, 2024
Fast Fashion and Sustainability are not friends and do not go well with each other: Namrata Joshipura, one of India’s most celebrated Fashion designers February 14, 2024
YFLO to organise a session Design Your StoryFebruary 14, 2024
Starkey Launches Genesis AI Hearing Aids in India, Pioneering a New Era in Hearing HealthFebruary 14, 2024
Indian Institute of Heritage and University of Birmingham announce strategic partnershipFebruary 14, 2024
Siddharth Anand’s Fighter emerges as the first hit of 2024February 13, 2024
India’s 26 years old youth’s Adventurous Atal Yatra to Celebrate Silver Jubilee of the Golden Quadrilateral beginsFebruary 13, 2024
Vitafoods India 2024 - Exploring Nutraceutical FrontiersFebruary 13, 2024